Cannara Biotech Revenues Rise as Expansion Brings in More Profit

Cannara
Cannara achieved a market share of 9.3% in Quebec and 3% in Ontario in March 2023.

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) posted meaningful rises in net revenues for its fiscal second quarter results ending Feb. 28.

The vertically integrated Canadian producer reported a 76% revenue increase, reaching $13 million, compared to the same period last year. The increase is attributed to the company’s expanding workforce and increased growing capacity.

“In the past quarter, Cannara achieved unprecedented revenue, bolstered gross profits, and enhanced adjusted EBITDA, reflecting our unwavering commitment to executing the growth strategy we envisioned from the start,” president and CEO Zohar Krivorot said in a statement. “Our market share has made significant strides in

According to estimated sales data from Trellis Distribution Insights, Cannara achieved a market share of 9.3% in Quebec and 3% in Ontario in March 2023. The company said success in these areas is due to product quality and customer satisfaction. The company is set to launch 17 new SKUs in Ontario this summer and is preparing to enter the Alberta market.

“When compared to the second quarter of 2022, our financial performance across all metrics has seen substantial improvement,” CFO Nicholas Sosiak said. “This remarkable growth led to the expansion of our workforce, which was crucial in activating additional growing zones.”

Cannara reported a positive operating income of $600,000 for the quarter, an increase of 250% compared to the same period in 2022.

In addition, the company delivered its eighth consecutive quarter of positive adjusted EBITDA, reporting $3.2 million for the quarter, a 1500% increase compared to the same period in 2022, and $4.9 million for the first half of fiscal year 2023, a 346% increase compared to the same period in 2022.

The net loss for the quarter was $600,ooo – a 50% improvement versus a net loss of $1.2 million for the same period in 2022. However, without the $1.4 million inventory write-down, the company would have achieved a net income figure of $800,000 for the quarter.

Cannara also reported an increase in free cash flow, with $1.9 million for the quarter, up 850% compared to the same period in 2022, and $3.8 million for the first half of fiscal year 2023, a 171% increase compared to the same period in the prior year.

The company has $25.6 million in working capital as of Feb. 28, including $4.1 million of cash on hand.

In addition to expanding its market share, Cannara designed and launched a new line of apparel and accessories for sale on its platform. The initiative is aimed at diversifying its revenue streams and catering to a broader audience.

And as the company continues to “purposively build out our product offerings across our three flagship brands and enter new markets,” Krivorot said, the company also launched an online community channel to engage and support their customers.

Avatar photo

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.


One comment

  • michael g mclaughlin

    April 24, 2023 at 11:10 pm

    It seems many if not most of the cannabis companies are infatuated with “building out” everything from products to dispensaries to grows.
    And they do this with borrowed money. Growing a company organically from revenues is not the modern American business practice.

    Reply

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets